Found 94 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K. Gwinn, Odenkirchen, J., Krotoski, D., Sheikh, M., Ala'i, S., and Esterlitz, J., A Common Language for Clinical Research Studies: The National Institute of Neurological Disorders and Stroke (NINDS) Mitochondrial Disease Common Data Elements (CDE), in United Mitochondrial Disease Foundation Symposium, Herndon, VA, 2015.
C. Gurgol, Foley, A., Belt, P., Denzen, E., Duffy, S., Gallagher, C., Grodman, C., Horowitz, M., Confer, D., and Carter, S., Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster)., in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
A. Guimarães-Walker, Mackie, N., McMichael, A., Weber, J., McCormack, S., Cebere, I., Kay, R., Hanke, T., Dally, L., Gibiansky, L., Legg, K., DeSouza, C., Hayes, P., Gilmour, J., and Fast, P., Priming with a Candidate HIV-1 Clade A DNA Vaccine Followed by Boosting with an HIV-1 Clade A MVA Vaccine in Volunteers at Low risk of HIV Infection, in AIDS Vaccine 2004 International Conference, Lausanne, Switzerland, 2004.
A. Guimarães-Walker, Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., Barin, B., McMichael, A., Weber, J., Legg, K., Babiker, A., Hayes, P., Gotch, F., Smith, C., Dally, L., Dorrell, L., Cebere, I., Kay, R., Winstone, N., Moore, S., Goonetilleke, N., and Fast, P., Lessons from IAVI-006, a Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the PTHR.HIVA DNA and MVA.HIVA Vaccines in a Prime-Boost Strategy to Induce HIV-1 Specific T-Cell Responses in Healthy Volunteers, Vaccine, vol. 26, no. 51, pp. 6671-6677, 2008.
J. Gryczynski, McNeely, J., Wu, L. - T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., Sharma, A., Mitchell, S. G., O'Grady, K. E., and Schwartz, R. P., Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care, J Gen Intern Med, 2017.
Baseline Nutritional Status of AREDS Participants, Poster Presentation by AREDS Participants, Experimental Biology, 1999.
Report from the Studies of Pediatric Liver Transplantation (SPLIT) Research Group, 1998.
Potential public health impact of Age-Related Eye Disease Study results. AREDS Report No.11, Arch Ophthalmol, vol. 121, pp. 1621-1624, 2003.
J. P. SanGiovanni, Chew, E., Clemons, T., III, F. L. Ferris, Gensler, G., Lindblad, A. S., Milton, R., Seddon, J. M., and Sperduto, R., The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22, Arch Ophthalmol, vol. 125, pp. 1225-1232, 2007.
Associations of Mortality with Ocular Disorders and an Intervention of High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study. AREDS Report No. 13, Archives of Ophthalmology, vol. 122, pp. 716-726, 2004.
Extension of the Wisconsin Lens Opacity Grading System., 1997.
Risk Factors Associated with Age-Related Nuclear and Cortical Cataract - A Case-Control Study in the Age-Related Eye Disease Study. AREDS Report No. 5, Ophthalmology, vol. 108, pp. 1400-1408, 2001.
Development and Valuation of a Food Frequency Questionnaire in a Randomized Trial of Eye Diseases, in Conference on Dietary Assessment Measures, 1998.
Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry, Pediatr Pulmonol, vol. 35, pp. 484-9, 2003.
Development and Validation of a Food Frequency Questionnaire in a Randomized Trial of Eye Diseases, 1999.
N. Huynh, Nicholson, B. P., Agron, E., Clemons, T. E., Bressler, S. B., Rosenfeld, P. J., and Chew, E. Y., Visual Acuity After Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5, Ophthalmology, vol. 121, pp. 1229-1236, 2014.
AREDS Update I: The Effect of Cataract Surgery on Progression to Advanced AMD, in American Academy of Ophthalmology Meeting, Anaheim, CA, 2003.
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. Age-Related Eye Disease Study Report No. 8, Archives of Ophthalmology, vol. 119, no. 10, pp. 1417-1436, 2001.
L. Aiello, Davis, M., Girach, A., Kles, K., Milton, R., Sheetz, M., Vignati, L., and Zhi, X., Effect of Ruboxistaurin on Visual Loss in Patients With Diabetic Retinopathy, Ophthalmology, vol. 113, no. 12, pp. 2221-2230, 2006.
The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants-Age-Related Eye Disease Study Report No. 2, J Nutrition, vol. 130, p. 1516S-19S, 2000.
National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10, Arch Ophthalmol, vol. 121, pp. 211-217, 2003.
The Age-Related Eye Disease Study System for Classifying Age-Related Macular Degeneration from Stereoscopic Color Fundus Photographs: The Age-Related Eye Disease Study Report Number 6, Am J Ophthalmol, vol. 132, pp. 668-81, 2001.
The Effect of Ruboxistaurin on Visual Loss in Patients with Moderately Severe To Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of The Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Clinical Trial, Diabetes, vol. 54, pp. 2188-2197, 2005.
Design Implications. AREDS Report No. 1, Control Clin Trials, vol. 20, no. 6, pp. 573-600, 1999.
AREDS Update II: Mortality and Nutritional Risk Factors, in American Academy of Ophthalmology Meeting, Anaheim, CA, 2003.